An open-label pilot study of Herceptin monotherapy on objective treatment response in patients with metastatic or locally advanced gastric cancer who had disease progression during platinum-based or 5-fluoropyrimidine-based chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 22 Aug 2014
At a glance
- Drugs Trastuzumab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Roche
- 09 Aug 2014 Status changed from completed to discontinued as reported by ClincialTrials.gov.
- 16 Feb 2008 Status changed from in progress to completed.
- 23 Jan 2008 Status changed from recruiting to in progress.